Health ❯ Healthcare ❯ Pharmaceuticals

Weight Loss

GLP-1 Drugs Mounjaro Wegovy GLP-1 Medications Obesity Treatments Semaglutide GLP-1 Receptor Agonists Clinical Trials Obesity Treatment Orforglipron Tirzepatide Ozempic GLP-1 Agonists Injections GLP-1 Treatments Weight Loss Drugs Eli Lilly Medications Medication GLP-1 Therapies Weight Loss Injections Zepbound Amycretin CagriSema Novo Nordisk Ozempic and Wegovy Adverse Reactions Obesity Drugs Muscle Health Market Availability Orforpligron Celebrity Endorsements Mounjaro (Tirzepatide) Drug Development Obesity Accessibility Pricing Medical Incidents Unapproved Drugs Semaglutide Injection Eloralintide Tirzepatida AI-Generated Content Medication Switching Oral Medications Regulation of Medicines Hormonal Treatments Medication Efficacy Compounded Medications Anti-Obesity Medications Generic Drugs Anti-Obesity Drugs Drug Comparison Cagrisema Online Purchases GLP-1 Injections Drug Pricing Drug Trials Prescription Drugs Illegal Drugs Compounded Drugs Microdosing Prescription Medications Amylin Analogs Drug Approval GLP Agonist Drugs Injectable Drugs Orforgilpron Ecnoglutida Weight Loss Pills

BMJ Review Flags Rapid Weight Regain After GLP‑1 Stop as UK Approves Higher‑Dose Wegovy

Clinicians urge long‑term maintenance to protect weight and metabolic gains.

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

Novo Nordisk Launches Wegovy Weight‑Loss Pill in U.S. at $149 Starter Price

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

Novo Nordisk Files for 7.2 mg Wegovy Dose After Stronger Weight-Loss Results

Stopping GLP-1 Weight-Loss Drugs Before Pregnancy Linked to Higher Gestational Risks, Study Finds

Lancet Phase 3 Trial Shows Oral GLP-1 Orforglipron Aids Weight Loss and Diabetes Control

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

Innovent Says Mazdutide Tops Semaglutide in China Phase 3 Diabetes Trial

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials

Sam’s Club Joins Costco in Offering $499 Wegovy and Ozempic

Costco to Offer Ozempic and Wegovy for $499 a Month to Self-Pay Members Nationwide

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide

Lilly’s Orforglipron Pill Hits Phase 3 Goals and Outperforms Oral Semaglutide in Diabetes Study

Triple-Dose Semaglutide Outperforms Standard Regimen in Weight-Loss Trials

Half of Semaglutide Users Quit Within a Year as Higher Dose Trials Show Bigger Losses, More Side Effects

Australian Study Finds Contraception Gaps and Pregnancies After GLP-1 Weight-Loss Prescriptions